| Name | Title | Contact Details |
|---|
Magellan Diagnostics is a North Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Warm Springs Rehabilitation System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Warm Springs Rehabilitation System is based in San Antonio, TX. You can find more information on Warm Springs Rehabilitation System at www.warmsprings.org
Integrated Behavioral Health (IBH) provides innovative technology based tools and effective treatments for employee assistance, workers compensation programs, substance abuse and opioid addiction, behavioral health, and wellness management. For over 35 years, IBH serves over 38K employers and supports 10 million employees and their families. With a focus on positive outcomes through clinically validated methods and tools, IBH reduces claims and costs for organizations while improving the lives of its people.
Complete Senior Care is a Niagara Falls, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.